Equities

Shanghai Haoyuan Chemexpress Co Ltd

688131:SHH

Shanghai Haoyuan Chemexpress Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)36.80
  • Today's Change-2.06 / -5.30%
  • Shares traded2.55m
  • 1 Year change-15.91%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Shanghai Haoyuan Chemexpress Co Ltd had net income fall -34.18% from 193.64m to 127.45m despite a 38.44% increase in revenues from 1.36bn to 1.88bn. An increase in the cost of goods sold as a percentage of sales from 51.71% to 59.22% was a component in the falling net income despite rising revenues.
Gross margin44.42%
Net profit margin7.08%
Operating margin7.17%
Return on assets3.42%
Return on equity5.90%
Return on investment4.66%
More ▼

Cash flow in CNYView more

In 2023, Shanghai Haoyuan Chemexpress Co Ltd did not generate a significant amount of cash. Cash Flow from Financing totalled 409.21m or 21.77% of revenues. In addition the company used 63.61m for operations while cash used for investing totalled 328.51m.
Cash flow per share--
Price/Cash flow per share--
Book value per share12.84
Tangible book value per share10.87
More ▼

Balance sheet in CNYView more

Shanghai Haoyuan Chemexpress Co Ltd has a Debt to Total Capital ratio of 32.29%, a higher figure than the previous year's 17.47%.
Current ratio1.96
Quick ratio1.01
Total debt/total equity0.4799
Total debt/total capital0.3229
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -44.74% and -36.02%, respectively. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)20.30%
EPS growth(5 years)46.40
EPS (TTM) vs
TTM 1 year ago
-1.82
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.